跳至主要内容
临床试验/RPCEC00000239
RPCEC00000239尚未招募2 期

Weekly paclitaxel concurrent with radiation therapy/Cisplatin in patients with cervical cancer of clinical stages IIb- IVA: PACORTCC study - PACORTCC

Cancerology State Institute, Colima State Health Service (SSA-Colima), Mexico0 个研究点目标入组 30 人开始时间: 2017年2月17日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Single Blind. Control group: Active. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
18 years 至 one(—)
性别
All

入选标准

  • 1. Women older than 18 years
  • 2. Clinical and histological diagnosis of CaCU EC IIB-IVA.
  • 3. Histology of epidermoid carcinoma, adenocarcinoma, adenosquamous.
  • 4. ECOG 0-2.
  • 5. Patients with no history of Hepatic insufficiency or creatinine clearance less than 30mil / min.
  • 6. Patients without sensory or motor neuropathy from any cause

排除标准

  • 1. Histology of small cells.
  • 2. ECOG 3 or greater.
  • 3. Diagnosis of second primary cancer.
  • 4. Patients with diagnosed pregnancy.

研究者

发起方
Cancerology State Institute, Colima State Health Service (SSA-Colima), Mexico

相似试验